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Crystallization of undercooled liquid fenofibrate†
Esther Amstad,ab Frans Spaepena and David A. Weitz*ac
Formulation of hydrophobic drugs as amorphous materials is highly advantageous as this increases their
solubility in water and therefore their bioavailability. However, many drugs have a high propensity to
crystallize during production and storage, limiting the usefulness of amorphous drugs. We study the
crystallization of undercooled liquid fenofibrate, a model hydrophobic drug. Nucleation is the rate-
limiting step; once seeded with a fenofibrate crystal, the crystal rapidly grows by consuming the
undercooled liquid fenofibrate. Crystal growth is limited by the incorporation of molecules into its
surface. As nucleation and growth both entail incorporation of molecules into the surface, this process
likely also limits the formation of nuclei and thus the crystallization of undercooled liquid fenofibrate,
contributing to the good stability of undercooled liquid fenofibrate against crystallization.
Introduction
The bioavailability of hydrophobic drugs is often limited by their
poor water solubility; this can severely reduce their eﬀectiveness
as medication.1 The eﬀectiveness of such drugs strongly increases
if they are formulated as amorphous materials, as the amorphous
phase has a higher free energy and thus a higher solubility; hence,
it dissolves faster and in larger quantities than the crystal.2,3
However, it is diﬃcult to make drugs amorphous as many of
them have a high propensity to crystallize.4 To overcome this
diﬃculty, large quantities of crystallization-inhibiting polymers
can be added.5 Although drugs can be made amorphous, their
use is still very limited as it is even more diﬃcult to prevent
crystallization during storage; this is especially the case if drugs
are kept at temperatures close to their glass transition tem-
perature, Tg, as many drugs are.
6 This spontaneous phase
transformation occurs even if they are stabilized with
crystallization-inhibiting polymers;7 it uncontrollably changes
the bioavailability and limits the utility of amorphous drugs.
A qualitative improvement of the stability of amorphous drugs
requires a better understanding of the most important para-
meters that drive crystallization. This understanding is diﬃcult
to obtain, as the crystallization of amorphous drugs, formulated
in the presence of polymeric additives, strongly depends on the
additive itself.5 It is much easier to gain this understanding from
additive-free amorphous drugs; such drugs can be conveniently
produced using a microfluidic nebulator.8 However, studies on
the crystallization of pure amorphous drugs remain rare.
In this paper, we study the crystallization of undercooled
liquid fenofibrate, a hydrophobic model drug. Even though its
crystallization is limited by nucleation, both the nucleation and
growth processes entail the incorporation of solute molecules
into crystalline surfaces; hence, their rates are influenced by
similar kinetic parameters. We study crystal growth since this
process is easier to visualize; it is diﬀusion-limited and thus
strongly temperature-dependent. However, diﬀusion only accounts
for the frequency with which molecules impinge on a surface; it
does not account for the probability of impinging molecules to
insert themselves into the crystal. This probability is very low
for fenofibrate, an anisotropic molecule, and slows down the
crystal growth by more than two orders of magnitude under the
conditions of these experiments.
Results and discussion
We fabricate the nebulator from poly(dimethyl siloxane) (PDMS)
using soft lithography.9 It contains two inlets for liquids and six
inlets for air. Liquid is injected into the main channel before the
first pair of air inlets intersects the main channel at an angle of
1351. The air pushes ethanol towards the four channel walls,
forming thin ethanol films that flow along these walls while the
air flows through the center of the channel. The subsequent air
inlets intersect the main channel at an angle of 451, as shown in
Fig. S1 (ESI†); the air inserted through these inlets accelerates the air
in the main channel, thereby thinning the ethanol films. The last
junction is three-dimensional (3D)10 to push the ethanol films away
from all four walls of the last part of the main channel, thereby
breaking the ethanol films into very small drops that rapidly dry.8
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We use fenofibrate as a hydrophobic model drug; amor-
phous fenofibrate is an undercooled liquid at room tempera-
ture since it has a glass transition temperature, Tg, of 20 1C7
and a melting temperature, Tm, of 80 1C.
11 We dissolve feno-
fibrate in ethanol at 5 mg ml1, and inject the solution through
one liquid inlet at 1 ml h1 using syringe pumps; we block the
second liquid inlet to avoid leakage of the liquid and the air.
We introduce air by applying 0.28 MPa to all the air inlets and
collect the spray dried undercooled liquid drops 15 cm apart
from the nozzle on a flat substrate.8
The nebulator produces amorphous undercooled liquid feno-
fibrate drops with diameters as small as 14 nm;12 the volume of a
single drop is as low as 1021 l. However, as amorphous feno-
fibrate is an undercooled liquid at room temperature, drops
coalesce as soon as they come in contact with each other. The
larger volume of the resulting coalesced drops increases the
probability for a crystal nucleus to form in each drop.13 Remark-
ably, even if we coalesce suﬃcient drops to form a drop as large as
600 pl, fenofibrate remains amorphous for at least 5 days if stored
at room temperature under ambient conditions. However, once
seeded with a crystal nucleus of a diameter between 35 mm and
70 mm, three dimensional crystals grow very rapidly by consuming
some of the amorphous phase; it takes less than a minute to grow
dendritic crystals several 100 mm in size, as shown in time-lapse
optical micrographs in Fig. 1a–d, indicating that nucleation is the
rate-limiting step in the crystallization process.
The formation of crystal nuclei is diﬃcult to study quantita-
tively. However, nucleation involves the incorporation of solute
molecules into a crystal surface; the same process also occurs
during crystal growth, which is much easier to access experi-
mentally. Thus, we estimate the temperature-dependent rate
at which molecules are incorporated into the crystal surface
by quantifying the growth kinetics of the dendrite tips. We
measure the distance dendrite tips grow per unit as a function
of the temperature, T, using time-lapse optical micrographs
and calculate the dendrite growth velocity. During the early and
intermediate stages of the crystal growth the growth rate is,
within experimental error, constant. By contrast, the growth
rate continuously decreases during the final stages of crystal
growth. Hence, we only quantify the growth rate during the
early and intermediate stages. As we increase the temperature,
the undercooling DT = Tm – T decreases; here Tm is the melting
temperature of fenofibrate; this reduces the driving force for
crystal growth.13 Despite the reduced driving force, crystals
grow faster with increasing temperature, as shown in Fig. 1e.
The increasing growth rate of crystals with increasing tem-
perature indicates that crystal growth is diﬀusion-limited.
Factors limiting the growth rate of fenofibrate crystals must
thus include the jump frequency of the molecule from the
liquid to the crystal, k, and the probability that impacting
molecules are incorporated into the surface, which is described
by the site factor, f. The diﬀusional jump frequency k ¼ 6D
l2
depends on the diﬀusion coeﬃcient, D, as well as the jump
distance, l, which we take as the longest dimension of a
fenofibrate molecule, 1.5 nm;14 it is independent of the mecha-
nism by which crystals grow.
To investigate the growth mechanism, we determine the
temperature-dependence of f. We describe the growth velocity
as v ¼ kf l 1 exp  Dm
kBT
  
; here, Dm is the diﬀerence in the
chemical potential of a molecule in the crystal and in
the undercooled liquid, kB the Boltzmann constant, and T the
absolute temperature. We calculate Dm ¼ DHmDT
TmNAv
as a function
of the undercooling using the latent heat of fenofibrate, DHm =
28.8 kJ mol1, and its melting temperature, Tm = 80 1C, which
we determine with diﬀerential scanning calorimetry (DSC)
(Fig. 2); here NAv is Avogadro’s number. In addition, we quantify
the diﬀusional jump frequency k ¼ 6D
l2
¼ 2kBT
pZl3
using the Stokes–
Einstein relation for the last equality and the temperature-
dependent values for the viscosity of fenofibrate, Z.4 We
subsequently calculate f as a function of temperature. At room
temperature, the site factor is as low as 0.01 and further
decreases with increasing temperature, as shown in Fig. 1f.
These small values slow down crystal growth. Moreover, the
increase in f with increasing undercooling, DT, suggests that
the crystal growth is limited by the layer nucleation on the
crystal face, as detailed in the ESI.†
The key parameter in the nucleation of a crystal is the ledge
energy, gle, associated with the side surface of the layer nucleus.
13
Fig. 1 (a–d) Time-lapse confocal microscopy images of undercooled
liquid fenofibrate seeded with a fenofibrate crystal at (a) 293 K, (b) 303 K,
(c) 313 K, and (d) 323 K. The time after contact of the crystalline nucleus
with the undercooled liquid fenofibrate drop is indicated in the insets.
(e) The maximum growth rate of the dendrite tip as a function of the
temperature at which the undercooled liquid is crystallized. (f) The prob-
ability for fenofibrate molecules to insert themselves into the surface, f, is
shown as a function of the undercooling, DT.
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To compute gle, we express the site factor as f ¼ l2ns
 1
3fl
2
3is
1
3;
here ns* is the surface concentration of critical layer nuclei, fl is
the site factor for the ledge of a layer, and is* the number of
molecules along the edge of a critical layer nucleus. The site factor
for a ledge is typically much larger than that for a surface since
ledges are usually rough;15 we thus take fl E 1. The number of
molecules in a critical layer nucleus is small and we approximate
is*E 1. We confirm the accuracy of this assumption by determin-
ing the size of the critical nucleus after we have calculated the
ledge energy. The surface concentration of critical nuclei,
ns
 ¼ 1
l2
exp  ws

kBT
 
, depends on the work for these critical
nuclei to form, ws ¼ pgle
2l
Dmv
. This work is a balance between the
energy per unit length required to form a ledge, gle, and the energy
gained by forming a crystal. The gained energy is equal to the
diﬀerence in the chemical potential per unit volume, Dmv ¼
Dm
V
;
here %V is themolecular volume of fenofibrate. Thus, we approximate
the interfacial site factor as f ¼ exp  ws

3kBT
 
. Using the values of f,
shown in Fig. 1f, we calculate the ledge energy to be gle = 14mJm
2.
Indeed, this value is nearly independent of the temperature, despite
the temperature-dependence of f and Dmv, as shown in the ESI,†
supporting the validity of the layer nucleation mechanism.
As crystallization of fenofibrate is limited by the nucleation
of a crystal, the stability of amorphous fenofibrate strongly
depends on the rate at which stable crystal nuclei form. We
experimentally determine an upper limit of the crystal nuclea-
tion rate, Io 1
VdDt
; here Vd is the volume of a drop and Dt the
time it takes for a drop to crystallize. We spray dry undercooled
liquid fenofibrate drops with diﬀerent volumes and measure
the time it takes them to crystallize. Well-separated drops as
small as 1021 l remain liquid for more than 7 months if stored
at room temperature.8 If we increase the volume of the drops to
0.1–1 pl, they show no sign of crystallinity after 1 day storage in
an aluminum DSC pan, as indicated by the absence of any
melting peaks in DSC trace 1 of Fig. 2. However, they do start to
crystallize within 4 days, as indicated by the melting peak in
trace 2 of Fig. 2. Even more of these drops spontaneously
crystallize after having been stored for 8 days, as indicated by
the larger melting peak in trace 3 in Fig. 2. If we increase the
volume of drops by 11 orders of magnitude to VdE 600 pl, they
only remain liquid for approximately Dt = 5 days. Thus, we
obtain Io 1
VdDt
 3:8 106 m3 s1 at room temperature.
A crystal nucleus becomes supercritical and thus stable
when the energy gained from adding an additional molecule
Dm, is higher than the energy needed to create additional
crystal-melt interface; the energy of this additional crystal-
melt interface per unit area is g. For a spherical nucleus, the
critical radius is r ¼ 2g
Dmv
. To determine r*, we use the classical
nucleation theory to describe the nucleation rate
I ¼ fknZ exp  w

kBT
 
; here, n is the number of molecules per
unit volume, Z the Zeldovich factor, and w ¼ 16p
3
g3
Dmvð Þ2
the
work to form a spherical nucleus.13 From the density of feno-
fibrate, we get n = 2  1027 m3 s1. Taking the lower limit of ZZ
0.01,13 the measured values for f and Dmv, and the calculated
values for k, we estimate a lower limit for g Z 15 mJ m2; this
value is close to that of the ledge energy gle. At room temperature,
this surface energy results in a radius of a critical nucleus
Fig. 2 Diﬀerential scanning calorimetry (DSC) traces of spray dried
undercooled liquid fenofibrate drops with a diameter of 14 nm. Traces
were acquired (1) 0 d, (2) 4 d, and (3) 8 d after preparation. Samples are
stored in an aluminum DSC pan under ambient conditions. (4) Reference
spectrum of bulk fenofibrate.
Fig. 3 (a–d) Scanning electron micrographs of undercooled liquid fenofibrate drops spray dried by applying (a) 0.28 MPa, (b) 0.24 MPa, (c) 0.21 MPa, and
(d) 0.17 MPa to the inlets of the microfluidic nebulator. (e) Size-dependent melting point depression of fenofibrate. The slope of the linear fit through the
origin allows calculation of Dg, the difference of the surface energies between the free surfaces at the liquid and crystalline phase.
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of approximately 1.8 nm; such a nucleus contains approximately
26 fenofibrate molecules.14 Despite of the small size of the
critical crystal nucleus, it takes time for them for such nuclei
to form, as the probability for fenofibrate molecules to incorpo-
rate in a crystal, f, is very low.
Once the crystal growth is complete, a particle of radius rp is
formed whose chemical potential diﬀers from that of the bulk
by Dm ¼ 2gc
V
r
; here gc is the crystal free energy. Since the
surface energy of the liquid, gl, is usually lower than that of
the crystal, gc, the melting temperature is shifted, according to
the Gibbs-Thompson relation DT ¼ Tm;b  Tm;p ¼ 2Dg
VTm
rDHm
;
here Tm,b is the melting point of the bulk, Tm,p that of the
particle, and Dg ¼ gc  gl. We spray dry particles with a narrow
size distribution, having diameters between 20 nm and 25 nm
by controlling the pressure applied to the air inlets of the
nebulator.8 We measure their sizes from scanning electron
microscopy (SEM) images, as shown in Fig. 3a–d, quantify DT
using differential scanning calorimetry (DSC),8 and plot DT as a
function of the inverse particle diameter. Indeed, the melting
point depression increases with decreasing particle size, as
shown in Fig. 3e. We perform a linear fit of the data through
the origin to obtain the difference between the surface energy
of the crystal and the liquid Dg = 4.5 mJ m2, a plausible value.
Conclusions
The crystallization of undercooled liquid fenofibrate is limited
by nucleation. Even though we only show that the incorpora-
tion probability of molecules arriving at the surface is the rate-
limiting step of the crystal growth, we expect the same parameter
also to limit the nucleation as both processes, nucleation and
growth, entail the incorporation of molecules into a crystal surface.
Thus, the low insertion probability of fenofibrate molecules into
the crystal slows down the nucleation of crystals, thereby enhan-
cing the stability of the undercooled liquid. This is a contributing
reason why undercooled liquid fenofibrate does not instanta-
neously crystallize and, if compartmentalized into small drops,
displays an unprecedented stability against crystallization.
Acknowledgements
This work was supported by the NSF (DMR-1310266) and the
Harvard MRSEC (DMR-1420570). Part of this work was per-
formed at the Center for Nanoscale Systems (CNS), a member of
the National Nanotechnology Infrastructure Network (NNIN),
which is supported by the National Science Foundation under
NSF award no. ECS-0335765. CNS is part of Harvard University.
Notes and references
1 R. Laitinen, K. Lobmann, C. J. Strachan, H. Grohganz and
T. Rades, Int. J. Pharm., 2013, 453, 65–79.
2 C. Brough and R. O. Williams, III, Int. J. Pharm., 2013, 453,
157–166.
3 Y. Kawabata, K. Wada, M. Nakatani, S. Yamada and
S. Onoue, Int. J. Pharm., 2011, 420, 1–10.
4 J. A. Baird, D. Santiago-Quinonez, C. Rinaldi and L. S. Taylor,
Pharm. Res., 2012, 29, 271–284.
5 A. Paudel, Z. A. Worku, J. Meeus, S. Guns and G. Van den
Mooter, Int. J. Pharm., 2013, 453, 253–284.
6 P. A. Priemel, R. Laitinen, S. Barthold, H. Grohganz, V.-P. Lehto,
T. Rades and C. J. Strachan, Int. J. Pharm., 2013, 456, 301–306.
7 Y. C. Ng, Z. Yang, W. J. McAuley and S. Qi, Eur. J. Pharm.
Biopharm., 2013, 84, 555–565.
8 E. Amstad, M. Gopinadhan, C. Holtze, C. O. Osuji, M. P. Brenner,
F. Spaepen and D. A. Weitz, Science, 2015, 349, 956–960.
9 Y. N. Xia and G. M. Whitesides, Annu. Rev. Mater. Sci., 1998,
28, 153–184.
10 A. Rotem, A. R. Abate, A. S. Utada, V. Van Steijn and
D. A. Weitz, Lab Chip, 2012, 12, 4263–4268.
11 D. Law, W. L. Wang, E. A. Schmitt, Y. H. Qiu, S. L. Krill and
J. J. Fort, J. Pharm. Sci., 2003, 92, 505–515.
12 K. F. Kelton and A. L. Greer, Nucleation in condensed matter
applications in materials and biology, Elsevier, 2010.
13 R. F. Henry, G. Z. Zhang, Y. Gao and I. S. Buckner, Acta
Crystallogr., Sect. E: Struct. Rep. Online, 2003, 59, O699–O700.
14 W. K. Burton, N. Cabrera and F. C. Frank, Nature, 1949, 163,
398–399.
15 S. D. Peteves and R. Abbaschian, Metall. Trans. A, 1991, 22,
1271–1286.
Paper PCCP
Pu
bl
ish
ed
 o
n 
16
 O
ct
ob
er
 2
01
5.
 D
ow
nl
oa
de
d 
by
 E
CO
LE
 P
O
LY
TE
CH
N
IC
 F
ED
 D
E 
LA
U
SA
N
N
E 
on
 2
8/
10
/2
01
5 
19
:3
3:
20
. 
View Article Online
